Press Releases

Trinity Biotech Announces Q3 2024 Financial Results

November 15, 2024

Trinity Biotech Announces Q3 2024 Financial Results

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

November 7, 2024

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

October 25, 2024

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

October 25, 2024

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

September 25, 2024

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

September 19, 2024

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

September 12, 2024

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

September 4, 2024

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

August 27, 2024

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

August 21, 2024

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor

Trinity Biotech Announces Q2 2024 Financial Results

August 19, 2024

Trinity Biotech Announces Q2 2024 Financial Results

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

August 8, 2024

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

August 6, 2024

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Trinity Biotech Announces Appointment of A New CFO

July 12, 2024

Trinity Biotech Announces Appointment of A New CFO

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

May 24, 2024

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

May 16, 2024

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

May 9, 2024

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

April 4, 2024

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results Business Updates

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

February 28, 2024

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

February 28, 2024

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change